143 related articles for article (PubMed ID: 31328750)
1. Quantification of CYFRA 21-1 and a CYFRA 21-1-anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer.
Song KS; Nimse SB; Warkad SD; Oh AC; Kim T; Hong YJ
Chem Commun (Camb); 2019 Aug; 55(68):10060-10063. PubMed ID: 31328750
[TBL] [Abstract][Full Text] [Related]
2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
3. A novel immunoassay for the quantization of CYFRA 21-1 in human serum.
He A; Liu TC; Dong ZN; Ren ZQ; Hou JY; Li M; Wu YS
J Clin Lab Anal; 2013 Jul; 27(4):277-83. PubMed ID: 23852784
[TBL] [Abstract][Full Text] [Related]
4. Novel enzyme-free immunomagnetic microfluidic device based on Co
Proença CA; Baldo TA; Freitas TA; Materón EM; Wong A; Durán AA; Melendez ME; Zambrano G; Faria RC
Anal Chim Acta; 2019 Sep; 1071():59-69. PubMed ID: 31128756
[TBL] [Abstract][Full Text] [Related]
5. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantitation of cytokeratin-19 fragment and carcinoembryonic antigen in human serum via quantum dot-doped nanoparticles.
Chen Z; Liang R; Guo X; Liang J; Deng Q; Li M; An T; Liu T; Wu Y
Biosens Bioelectron; 2017 May; 91():60-65. PubMed ID: 27988480
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.
Patel JL; Erickson JA; Roberts WL; Grenache DG
Clin Biochem; 2010 Dec; 43(18):1449-52. PubMed ID: 20875814
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharide-enhanced ARGET ATRP signal amplification for ultrasensitive fluorescent detection of lung cancer CYFRA 21-1 DNA.
Wang X; Zhang Y; Zhao L; Wang D; Yang H; Kong J
Anal Bioanal Chem; 2020 Apr; 412(11):2413-2421. PubMed ID: 32047944
[TBL] [Abstract][Full Text] [Related]
9. Phthalocyanine-BODIPY dye: synthesis, characterization, and utilization for pattern recognition of CYFRA 21-1 in whole blood samples.
Stefan-van Staden RI; Comnea-Stancu IR; Yanık H; Göksel M; Alexandru A; Durmuş M
Anal Bioanal Chem; 2017 Oct; 409(26):6195-6203. PubMed ID: 28852796
[TBL] [Abstract][Full Text] [Related]
10. Electrochemiluminescence immunosensor for cytokeratin fragment antigen 21-1 detection using electrochemically mediated atom transfer radical polymerization.
Jian L; Wang X; Hao L; Liu Y; Yang H; Zheng X; Feng W
Mikrochim Acta; 2021 Mar; 188(4):115. PubMed ID: 33686530
[TBL] [Abstract][Full Text] [Related]
11. CYFRA 21-1 as a tool for distant metastasis detection in lung cancer.
Cabrera-Alarcon JL; Carrillo-Vico A; Santotoribio JD; Leon-Justel A; Sanchez-Gil R; Gonzalez-Castro A; Guerrero JM
Clin Lab; 2011; 57(11-12):1011-4. PubMed ID: 22239035
[TBL] [Abstract][Full Text] [Related]
12. Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream.
Sertić Milić H; Franjević A; Bubanović G; Marušić A; Nikolić I; Puljić I
Wien Klin Wochenschr; 2015 Jun; 127(11-12):465-71. PubMed ID: 25917364
[TBL] [Abstract][Full Text] [Related]
13. Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer.
Kammer MN; Kussrow AK; Webster RL; Chen H; Hoeksema M; Christenson R; Massion PP; Bornhop DJ
ACS Comb Sci; 2019 Jun; 21(6):465-472. PubMed ID: 31022347
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.
Park Y; Kim Y; Lee JH; Lee EY; Kim HS
Arch Pathol Lab Med; 2011 Dec; 135(12):1570-5. PubMed ID: 22129186
[TBL] [Abstract][Full Text] [Related]
15. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
17. CYFRA 21-1: an indicator of survival and therapeutic effect in lung cancer.
Takei Y; Minato K; Tsuchiya S; Takise A; Nakano H; Ezawa K; Fueki N; Hoshino H; Naruse I; Nomoto T; Makimoto T; Ishihara S; Saito R; Mori M
Oncology; 1997; 54(1):43-7. PubMed ID: 8978592
[TBL] [Abstract][Full Text] [Related]
18. A Fluorescent Sensor Based on Reversible Addition-Fragmentation Chain Transfer Polymerization for the Early Diagnosis of Non-small Cell Lung Cancer.
Liu W; Ma L; Guo Z; Liu T; Liu Y; Wang D; Kong J
Anal Sci; 2020 Jun; 36(6):681-685. PubMed ID: 31839663
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.
Lin Q; Chen XY; Liu WF; Zhu PW; Shi WQ; Li B; Yuan Q; Min YL; Liu JM; Shao Y
Cancer Med; 2020 Feb; 9(4):1279-1286. PubMed ID: 31218849
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.
Okamura K; Takayama K; Izumi M; Harada T; Furuyama K; Nakanishi Y
Lung Cancer; 2013 Apr; 80(1):45-9. PubMed ID: 23352032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
